Global Topical Hemostatic Agents Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Topical Hemostatic Agents Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Topical hemostatic agents are important adjuncts to reduce blood loss after cardiac surgery and can have a role in reducing both “surgical” and “nonsurgical bleeding.” There are many topical hemostatic agents to choose from, and with several new products in this field being approved for use in the last few years,
Topical Hemostatic Agents report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Topical Hemostatic Agents market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Surgical Centers are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Topical Hemostatic Agents industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Topical Hemostatic Agents key manufacturers include Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences and B Braun Melsungen, etc. Ethicon, Pfizer, Baxter International are top 3 players and held % sales share in total in 2022.
Topical Hemostatic Agents can be divided into Gelation Sponge, Oxidized Regenerated Cellulose Based Hemostats and Others,, etc. Gelation Sponge is the mainstream product in the market, accounting for % sales share globally in 2022.
Topical Hemostatic Agents is widely used in various fields, such as Hospitals, Surgical Centers and Nursing Homes,, etc. Hospitals provides greatest supports to the Topical Hemostatic Agents industry development. In 2022, global % sales of Topical Hemostatic Agents went into Hospitals filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Topical Hemostatic Agents market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Segment by Type
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Hospitals
Surgical Centers
Nursing Homes
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Topical Hemostatic Agents market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Topical Hemostatic Agents, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Topical Hemostatic Agents industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Topical Hemostatic Agents in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Topical Hemostatic Agents introduction, etc. Topical Hemostatic Agents Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Topical Hemostatic Agents market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Topical Hemostatic Agents report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Topical Hemostatic Agents market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Surgical Centers are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Topical Hemostatic Agents industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Topical Hemostatic Agents key manufacturers include Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences and B Braun Melsungen, etc. Ethicon, Pfizer, Baxter International are top 3 players and held % sales share in total in 2022.
Topical Hemostatic Agents can be divided into Gelation Sponge, Oxidized Regenerated Cellulose Based Hemostats and Others,, etc. Gelation Sponge is the mainstream product in the market, accounting for % sales share globally in 2022.
Topical Hemostatic Agents is widely used in various fields, such as Hospitals, Surgical Centers and Nursing Homes,, etc. Hospitals provides greatest supports to the Topical Hemostatic Agents industry development. In 2022, global % sales of Topical Hemostatic Agents went into Hospitals filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Topical Hemostatic Agents market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Segment by Type
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Segment by Application
Hospitals
Surgical Centers
Nursing Homes
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Topical Hemostatic Agents market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Topical Hemostatic Agents, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Topical Hemostatic Agents industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Topical Hemostatic Agents in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Topical Hemostatic Agents introduction, etc. Topical Hemostatic Agents Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Topical Hemostatic Agents market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices